La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « Claire Thiriez »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Claire Thalamas < Claire Thiriez < Claire Troakes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000075 (2015) Sonia Lavisse [France] ; Daniel García-Lorenzo [France] ; Marie-Anne Peyronneau [France] ; Benedetta Bodini [Royaume-Uni] ; Claire Thiriez [France] ; Bertrand Kuhnast [France] ; Claude Comtat [France] ; Philippe Remy ; Bruno Stankoff [France] ; Michel Bottlaender [France]Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
000119 (2014) Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugières [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni]Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
000141 (2014) Stéphane Palfi [France] ; Jean Marc Gurruchaga [France] ; G. Scott Ralph [Royaume-Uni] ; Helene Lepetit [France] ; Sonia Lavisse [France] ; Philip C. Buttery [Royaume-Uni] ; Colin Watts [Royaume-Uni] ; James Miskin [Royaume-Uni] ; Michelle Kelleher [Royaume-Uni] ; Sarah Deeley [Royaume-Uni] ; Hirokazu Iwamuro [France] ; Jean Pascal Lefaucheur [France] ; Claire Thiriez [France] ; Gilles Fenelon [France] ; Cherry Lucas [Royaume-Uni] ; Pierre Brugieres [France] ; Inanna Gabriel [France] ; Kou Abhay [France] ; Xavier Drouot [France] ; Naoki Tani [France] ; Aurelie Kas [France] ; Bijan Ghaleh [France] ; Philippe Le Corvoisier [France] ; Patrice Dolphin [France] ; David P. Breen [Royaume-Uni] ; Sarah Mason [Royaume-Uni] ; Natalie Valle Guzman [Royaume-Uni] ; Nicholas D. Mazarakis [Royaume-Uni] ; Pippa A. Radcliffe [Royaume-Uni] ; Richard Harrop [Royaume-Uni] ; Susan M. Kingsman [Royaume-Uni] ; Olivier Rascol [France] ; Stuart Naylor [Royaume-Uni] ; Roger A. Barker [Royaume-Uni] ; Philippe Hantraye [France] ; Philippe Remy [France] ; Pierre Cesaro [France] ; Kyriacos A. Mitrophanous [Royaume-Uni]Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Humans
2Male
2Middle Aged
1Adult
1Aged
1Antiparkinson Agents (administration & dosage)
1Antiparkinson Agents (adverse effects)
1Brain (diagnostic imaging)
1Cerebellum (diagnostic imaging)
1Clinical trial
1Dopa Decarboxylase (genetics)
1Dopamine (biosynthesis)
1Dopaminergic Neurons (metabolism)
1Dopaminergic Neurons (virology)
1Drug
1Female
1Fluorine Radioisotopes (chemistry)
1Follow-Up Studies
1GTP Cyclohydrolase (administration & dosage)
1GTP Cyclohydrolase (adverse effects)
1GTP Cyclohydrolase (genetics)
1Gene therapy
1Genetic Therapy (adverse effects)
1Genetic Therapy (methods)
1Genetic Vectors (administration & dosage)
1Genetic Vectors (adverse effects)
1Genotype
1Healthy Volunteers
1Image Processing, Computer-Assisted
1Increasing dose
1Infectious Anemia Virus, Equine (genetics)
1Inflammation (pathology)
1Injections, Intralesional
1Lentivirus
1Ligands
1Long term
1Medicine
1Neurodegenerative Diseases (diagnostic imaging)
1Parkinson Disease (therapy)
1Parkinson disease
1Phase I trial
1Phase II trial
1Polymorphism, Genetic
1Positron-Emission Tomography
1Protein Binding
1Putamen
1Pyrazoles (chemistry)
1Pyrimidines (chemistry)
1Receptors, GABA (metabolism)
1Safety
1Thalamus (diagnostic imaging)
1Transfection (methods)
1Transgenes (genetics)
1Treatment
1Tyrosine 3-Monooxygenase (administration & dosage)
1Tyrosine 3-Monooxygenase (adverse effects)
1Tyrosine 3-Monooxygenase (genetics)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Claire Thiriez" 
HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Claire Thiriez" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Claire Thiriez
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024